Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HCCI
3501
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $284K | ﹤0.01% |
7,969
+3,757
| +89% | +$135K |
|
3502
ANI Pharmaceuticals
ANIP
$1.8B
| $284K | ﹤0.01% |
7,141
+595
| +9% | +$25.1K |
|
3503
Castle Biosciences
CSTL
$855M
| $283K | ﹤0.01% |
12,454
+5,866
| +89% | +$143K |
|
|
EBTC
3504
DELISTED
Enterprise Bancorp
EBTC
| $283K | ﹤0.01% |
8,993
+2,233
| +33% | +$77K |
|
3505
Driven Brands
DRVN
$2.35B
| $282K | ﹤0.01% |
9,318
+5,415
| +139% | +$153K |
|
3506
UWM Holdings
UWMC
$617M
| $282K | ﹤0.01% |
57,466
+40,030
| +230% | +$176K |
|
3507
Kodiak Sciences
KOD
$2.6B
| $280K | ﹤0.01% |
45,201
+16,121
| +55% | +$113K |
|
|
NWLI
3508
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $279K | ﹤0.01% |
1,152
+541
| +89% | +$141K |
|
3509
AngioDynamics
ANGO
$611M
| $279K | ﹤0.01% |
26,973
+5,245
| +24% | +$67.1K |
|
3510
Enviri
NVRI
$623M
| $278K | ﹤0.01% |
40,701
+2,513
| +7% | +$18.9K |
|
3511
Axogen
AXGN
$2.27B
| $278K | ﹤0.01% |
29,411
+9,645
| +49% | +$88.2K |
|
3512
Brown-Forman Class A
BF.A
$13.4B
| $278K | ﹤0.01% |
4,258
-685
| -14% | -$44.6K |
|
3513
Dolby
DLB
$5.51B
| $278K | ﹤0.01% |
3,249
-891
| -22% | -$71.9K |
|
3514
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.55B
| $277K | ﹤0.01% |
7,411
-4,018
| -35% | -$154K |
|
3515
Vita Coco
COCO
$3.82B
| $277K | ﹤0.01% |
14,114
+6,627
| +89% | +$104K |
|
3516
Hyster-Yale Materials Handling
HY
$599M
| $275K | ﹤0.01% |
5,503
-665
| -11% | -$24.4K |
|
3517
Argan
AGX
$8B
| $274K | ﹤0.01% |
6,778
+3,261
| +93% | +$128K |
|
3518
Franklin Covey
FC
$242M
| $273K | ﹤0.01% |
7,107
+2,995
| +73% | +$138K |
|
3519
Tiptree Inc
TIPT
$662M
| $273K | ﹤0.01% |
18,764
+12,112
| +182% | +$184K |
|
3520
Voyager Therapeutics
VYGR
$183M
| $273K | ﹤0.01% |
35,436
+19,975
| +129% | +$159K |
|
|
WBA
3521
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $273K | ﹤0.01% |
+7,900
| New | +$280K |
|
|
AUY
3522
DELISTED
Yamana Gold, Inc.
AUY
| $273K | ﹤0.01% |
46,641
-185,837
| -80% | -$1.06M |
|
3523
AvePoint
AVPT
$2.76B
| $273K | ﹤0.01% |
66,221
+31,109
| +89% | +$140K |
|
3524
Lifestance Health
LFST
$4B
| $273K | ﹤0.01% |
36,689
+17,288
| +89% | +$95.9K |
|
3525
1-800-Flowers.com
FLWS
$250M
| $272K | ﹤0.01% |
23,657
+7,625
| +48% | +$78K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.